Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander J Thompson

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
Cancers|May 13, 2023
Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal MelanomaHelena Robinson, Antonio Eleuteri, Joseph J Sacco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 9, 2025
The hepatitis C cascade of care for opioid agonist therapy recipients in AustraliaSamara Griffin, Jason Asselin, Anna Lee Wilkinson, et al.
The Medical Journal of Australia|May 20, 2019
Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statementJoseph Doyle, Michelle Raggatt, Monica Slavin, et al.
Open Forum Infectious Diseases|March 27, 2026
A Costing Analysis of a Nurse- and Peer-Led Mobile Model of Hepatitis C Care Adjacent to the Community Corrections SettingSamara Griffin, Farah Houdroge, Nick Scott, et al.
The International Journal on Drug Policy|May 27, 2019
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility studyBridget Williams, Jessica Howell, Joseph Doyle, et al.
Hepatology Communications|September 12, 2018
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialMarlyn J Mayo, Alan J Wigg, Barbara A Leggett, et al.
Hepatology (Baltimore, Md.)|January 30, 2016
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)Vincent Leroy, Peter Angus, Jean-Pierre Bronowicki, et al.
The Medical Journal of Australia|March 6, 2022
Australian consensus recommendations for the management of hepatitis BJohn S Lubel, Simone I Strasser, Alexander J Thompson, et al.
The Journal of Infectious Diseases|June 11, 2016
Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus InfectionSwee Lin G Chen Yi Mei, Jodie Burchell, Narelle Skinner, et al.
Hepatology (Baltimore, Md.)|February 10, 2012
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific mannerPaul J Clark, Alexander J Thompson, David M Vock, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Cancers|May 13, 2023
Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal MelanomaHelena Robinson, Antonio Eleuteri, Joseph J Sacco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 9, 2025
The hepatitis C cascade of care for opioid agonist therapy recipients in AustraliaSamara Griffin, Jason Asselin, Anna Lee Wilkinson, et al.
The Medical Journal of Australia|May 20, 2019
Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statementJoseph Doyle, Michelle Raggatt, Monica Slavin, et al.
Open Forum Infectious Diseases|March 27, 2026
A Costing Analysis of a Nurse- and Peer-Led Mobile Model of Hepatitis C Care Adjacent to the Community Corrections SettingSamara Griffin, Farah Houdroge, Nick Scott, et al.
The International Journal on Drug Policy|May 27, 2019
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility studyBridget Williams, Jessica Howell, Joseph Doyle, et al.
Hepatology Communications|September 12, 2018
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialMarlyn J Mayo, Alan J Wigg, Barbara A Leggett, et al.
Hepatology (Baltimore, Md.)|January 30, 2016
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)Vincent Leroy, Peter Angus, Jean-Pierre Bronowicki, et al.
The Medical Journal of Australia|March 6, 2022
Australian consensus recommendations for the management of hepatitis BJohn S Lubel, Simone I Strasser, Alexander J Thompson, et al.
The Journal of Infectious Diseases|June 11, 2016
Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus InfectionSwee Lin G Chen Yi Mei, Jodie Burchell, Narelle Skinner, et al.
Hepatology (Baltimore, Md.)|February 10, 2012
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific mannerPaul J Clark, Alexander J Thompson, David M Vock, et al.
Pageof 18